Rock Springs Capital Management’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
DIG
CCM
WVP
GCP
WAM
KCM
Rock Springs Capital Management's GOSS Position: Q2 2026 in Review
Rock Springs Capital Management sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 1,609,492 shares — an estimated $529K sold.
Rock Springs Capital Management first reported a position in GOSS in Q3 2022 and held it in 15 quarters. The position peaked at $19M in Q3 2022. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.
- Rock Springs Capital Management reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
- Rock Springs Capital Management sold 1,609,492 Gossamer Bio shares in Q2 2026, an estimated $529K.
- Rock Springs Capital Management first reported a position in Gossamer Bio in Q3 2022 and held it in 15 quarters.
- Rock Springs Capital Management's Gossamer Bio position peaked at $19M in Q3 2022.
- 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.
Based on Rock Springs Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.